Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?
Borgwardt
Stefan
S
Smieskova
Renata
R
Bendfeldt
Kerstin
K
Bühlmann
Eva
E
Berger
Gregor
G
Aston
Jacqueline
J
Gschwandtner
Ute
U
Pflueger
Marlon
M
Stieglitz
Rolf-Dieter
RD
Riecher-Rössler
Anita
A
Radue
Ernst-Wilhelm
EW
D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D042241:Early Diagnosis; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009929:Organ Size / Q000187:drug effects; D011237:Predictive Value of Tests; D011605:Psychoses, Substance-Induced / Q000175:diagnosis; D011618:Psychotic Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000523:psychology; D012307:Risk Factors
D014150:Antipsychotic Agents